​Financial professional Bradley DiTeresi has more than 10 years’ experience in wealth management. A resident of Olathe, Kansas, Bradley DiTeresi enjoys conducting research on stocks.

Thorough stock research is the backbone of sound investing. It encompasses both quantitative and qualitative factors.

For quantitative stock research, investors rely heavily on the published financial statements that companies release. For example, publicly listed companies file a Form 10-Q with the U.S. Securities and Exchange Commission quarterly and a Form 10-K annually. These forms contain the company’s financial statements, including the income statement and balance sheet. As part of their stock research, investors read these statements to learn about a company’s revenue, expenses, profit/loss, assets, and liabilities. They can also compare a company’s current numbers with those from previous years or with companies in a similar industry to identify whether the company is growing or performing better than its peers.

Qualitative stock research, for its part, is an analysis of the non-technical aspects of a company. These include management expertise, innovative capability, and customer loyalty, among many others. Investors should prioritize investing in companies with good financial fundamentals as well as qualitative competitive advantages.

​The recipient of an MBA from the University of Kansas, Bradley DiTeresi is a financial service professional who pursues a wide range of hobbies and interests during his free time. Bradley DiTeresi maintains a strong community presence and is active in the Catholic Church. He is also known for his philanthropic endeavors, donating to organizations dedicated to Alzheimer's research and support, among other causes.

According to CBSNews.com, donanemab, a drug for stalling Alzheimer’s disease progression, has demonstrated its effectiveness in a 1,700-person clinical study by its manufacturer, Eli Lilly and Co. The Journal of the American Medical Association published the study, which shows that donanemab can stall Alzheimer’s by a few months. It also works better during the early stage of the disease.

As of July 2023, Eli Lilly is seeking US Food and Drug Administration approval for donanemab. If the FDA greenlights the drug, it would be the second it has approved for delaying Alzheimer’s disease.

Potentially disabling, Alzheimer’s is characterized by irreversible brain damage that erodes memory and cognitive function. As the disease progresses, it affects motor skills and causes the inability to singlehandedly perform daily tasks such as bathing, dressing, and eating. Alzheimer’s affects over 6.5 million Americans, according to the FDA.

​An accomplished financial professional in Kansas, Bradley DiTeresi holds a BA in psychology from the University of Kansas and an MBA from the University of Missouri. Bradley DiTeresi is also an active member of his community, dedicated to making a positive impact, and regularly donates to organizations such as the Lupus Foundation of America.

The Lupus Foundation launched Research Accelerated by You (RAY), a data platform whereby individuals with lupus and caregivers share their experiences to accelerate research, develop new treatments, and improve disease outcomes. The platform collects ongoing self-reported data, keeps it confidential, and shares anonymous information with researchers to enhance clinical trials and advance potential therapies. Lupus is a complicated auto-immune disease that affects people in different ways and often causes signs and symptoms like hair loss, numb and discolored fingers, swelling in the joints, extreme fatigue, and abnormal sensitivity to light.

People affected by lupus and their parents can join RAY online by completing a registration process and survey. While they help researchers accrue data for understanding lupus, RAY members also have the opportunity to compare their experiences with others and learn about new clinical trials and research studies.

​Bradley DiTeresi is an experienced finance professional with an MBA in finance and over a decade of experience. In his free time, avid philanthropist Bradley DiTeresi enjoys traveling and running.

Running is a popular pastime for many people worldwide. Most runners are constantly striving to improve their records and overall running ability. Fortunately, technological advancements have resulted in a variety of tools that allow you to measure your running performance, identify your weaknesses, and improve the effectiveness of your sessions, making the process of improving your fitness and efficiency easier than ever.

GPS watches are a standard tool used by runners to collect data on their running metrics. These watches use satellite tracking data to provide accurate data on your distance traveled and pace during runs, allowing you to track your progress and the effectiveness of your training routine. Also, depending on the model, your GPS watch may record heart rate data and cadence and footfall information.

Fitbit is a tool that can help you improve your running performance by providing accurate data on your fitness level. These devices track your steps, heart rate, water consumption, and food intake, among other things. While using the information gathered to provide you with recommendations on what aspects need improvement and how to improve them.

​Bradley DiTeresi is a financial professional and entrepreneur based in Olathe, Kansas. Also a practicing catholic, Bradley DiTeresi often donates to the Christian Foundation for Children and Aging (CFCA), the Lupus Foundation of America, and the Alzheimer's Association.

Alzheimer's is a progressive neurological disease that kills brain cells and causes the shrinking of the brain. It causes a person to slowly lose important memory functions, which makes them have difficulty remembering things, shorter attention spans, problems reading, writing, doing simple math, and logically organizing thoughts. The decline in mental health makes it impossible for a person with advanced Alzheimer's to function independently.

The disease mostly affects those above 65 years, and the Centers for Disease Control and Prevention (CDC) estimates there are 5.6 million people aged above 65 and 200,000 below 65 years with Alzheimer's in the US. CDC further estimates that there will be close to 14 million people living with Alzheimer's in the US by 2060 because every five years, the number of Alzheimer's cases reported doubles. Alzheimer's has no cure, but medication is available to help manage the symptoms. Regular exercise can also slow down Alzheimer's progression.

​Bradley DiTeresi earned an MBA in finance from the University of Missouri-Kansas City. He has built professional experience as a wealth and finance expert. Bradley DiTeresi enjoys many hobbies, such as running.

Running is a favored form of exercise worldwide. According to a 2020 report, approximately 50 million Americans partake in some running or jogging of some form. As with all sports or forms of exercise, it's important to have the necessary gear. And the right pair of running shoes is the first thing you should start with.

While you can run in just about any kind of shoes, wearing the proper footwear helps prevent pain and injury. And it still affords you flexibility and comfort of movement. Depending on where you usually run, you can choose between cross-training, trail-running, or road-running shoes. Cushioning (the thickness of the fabric beneath the midsole and the foam’s firmness) and heel drop are important factors to consider when picking your running shoes.